Growing community of inventors

Olsbrücken, Germany

Thorsten Litzenberger

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Thorsten LitzenbergerUgur Sahin (3 patents)Thorsten LitzenbergerPetra Simon (3 patents)Thorsten LitzenbergerChristian Bender (3 patents)Thorsten LitzenbergerClaudia Paret (3 patents)Thorsten LitzenbergerKirsten Vormbrock (3 patents)Thorsten LitzenbergerStefanie Hubich (3 patents)Thorsten LitzenbergerChristoph Hartmann (3 patents)Thorsten LitzenbergerThomas Bukur (3 patents)Thorsten LitzenbergerPetra Oehm (3 patents)Thorsten LitzenbergerThorsten Litzenberger (3 patents)Ugur SahinUgur Sahin (182 patents)Petra SimonPetra Simon (11 patents)Christian BenderChristian Bender (7 patents)Claudia ParetClaudia Paret (6 patents)Kirsten VormbrockKirsten Vormbrock (6 patents)Stefanie HubichStefanie Hubich (4 patents)Christoph HartmannChristoph Hartmann (4 patents)Thomas BukurThomas Bukur (3 patents)Petra OehmPetra Oehm (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Biontech Se (2 from 66 patents)

2. Biontech Ag (1 from 36 patents)

3. Tron-translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz (1 from 14 patents)

4. Tron Ggmbh (1 from 2 patents)

5. Tron—translationale Onkologie an Der Universitätsmedizin Mainz Gemeinnützige Gmbh (1 from 1 patent)

6. Tron—translationale Onkologie an Der Universitátsmedizin Der Johannes Gutenberg—universität Mainz Gemeinnützige Gmbh (23 patents)


3 patents:

1. 12410221 - Tumor antigens for determining cancer therapy

2. 11628209 - Tumor antigens for determining cancer therapy

3. 10188712 - Tumor antigens for determining cancer therapy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/30/2025
Loading…